Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2024-12-05 Major Shareholding Noti…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 3 pages 251.4KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' under the Corporations Act 2001 Section 671B, which is a Notice of Initial Substantial Holder. It details the substantial shareholding of Vanguard Group in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, and recent acquisitions of shares. This type of filing is a notification of a major shareholding change, specifically the crossing of a substantial holding threshold. It is not a financial report, earnings release, or management report, but a regulatory notification about share ownership. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2024-12-05 English
Notification of cessation of securities - MYX 4 pages 14.8KB
Major Shareholding Notification Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Mayne Pharma Group Limited. It provides specific information about securities that have ceased, including the number, reason for cessation, and dates. The document is a formal announcement to the ASX about changes in the company's issued capital due to cessation of securities. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about securities cessation, fitting the category of Major Shareholding Notification or similar. However, since it specifically reports cessation of securities (not shareholding threshold changes), the closest fitting category is Major Shareholding Notification (MRQ), which covers notifications of significant share ownership changes or securities status changes. The document length is under 5,000 characters and is a direct announcement, not a report or certification. Therefore, the best classification is MRQ with high confidence.
2024-12-05 English
Notification regarding unquoted securities - MYX 5 pages 16.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and contains detailed information about the issuance and conversion of unquoted securities into quoted ordinary shares. It includes specifics such as the number of securities issued, dates of issuance, and classification of securities. This type of document is a formal announcement related to changes in the company's capital structure, specifically the issuance and conversion of securities. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about securities issuance. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support this classification with high confidence.
2024-12-05 English
Notification regarding unquoted securities - MYX 6 pages 19.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics such as the number of securities issued, issue dates, and mentions compliance with ASX Listing Rules. The content is focused on the announcement of new securities issued, particularly performance rights to key management personnel. There is no financial statement, management discussion, or detailed financial analysis present. The document is a regulatory announcement about securities issuance rather than a full financial report or management report. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes.
2024-12-05 English
Notification regarding unquoted securities - MYX 6 pages 19.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G notification, which is a standard ASX form used to report the issue, conversion, or payment up of unquoted equity securities. It details the issuance of performance rights under an employee incentive scheme, including the number of securities issued, issue date, and information about key management personnel receiving the securities. The document is a regulatory announcement about a capital change event, specifically the issuance of new securities, rather than a full financial report or management discussion. It does not contain financial statements or detailed financial analysis but focuses on the issuance of securities and compliance with listing rules. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (6603 characters) and content confirm it is a full notification rather than a brief announcement or a report publication announcement.
2024-12-05 English
Change of Director's Interest Notice 3 pages 309.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including performance rights and ordinary shares, with specifics on the number of securities held before and after the change. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, earnings data, or management discussion. The document length is 4305 characters, which is consistent with a detailed insider trading report. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2024-12-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.